159 related articles for article (PubMed ID: 16177102)
1. IL-16 is critical for Tropheryma whipplei replication in Whipple's disease.
Desnues B; Raoult D; Mege JL
J Immunol; 2005 Oct; 175(7):4575-82. PubMed ID: 16177102
[TBL] [Abstract][Full Text] [Related]
2. Impaired immune functions of monocytes and macrophages in Whipple's disease.
Moos V; Schmidt C; Geelhaar A; Kunkel D; Allers K; Schinnerling K; Loddenkemper C; Fenollar F; Moter A; Raoult D; Ignatius R; Schneider T
Gastroenterology; 2010 Jan; 138(1):210-20. PubMed ID: 19664628
[TBL] [Abstract][Full Text] [Related]
3. IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.
Ghigo E; Barry AO; Pretat L; Al Moussawi K; Desnues B; Capo C; Kornfeld H; Mege JL
PLoS One; 2010 Oct; 5(10):e13561. PubMed ID: 21042409
[TBL] [Abstract][Full Text] [Related]
4. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.
Moos V; Kunkel D; Marth T; Feurle GE; LaScola B; Ignatius R; Zeitz M; Schneider T
J Immunol; 2006 Aug; 177(3):2015-22. PubMed ID: 16849516
[TBL] [Abstract][Full Text] [Related]
5. Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway.
Gorvel L; Al Moussawi K; Ghigo E; Capo C; Mege JL; Desnues B
Cell Death Dis; 2010 Apr; 1(4):e34. PubMed ID: 21364641
[TBL] [Abstract][Full Text] [Related]
6. -295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease.
Biagi F; Schiepatti A; Badulli C; Sbarsi I; Trotta L; Feurle GE; Müller C; Moos V; Schneider T; Marth T; De Amici M; Martinetti M; Corazza GR
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1919-21. PubMed ID: 26154181
[TBL] [Abstract][Full Text] [Related]
7. Whipple's disease and Tropheryma whipplei infections: from bench to bedside.
Boumaza A; Ben Azzouz E; Arrindell J; Lepidi H; Mezouar S; Desnues B
Lancet Infect Dis; 2022 Oct; 22(10):e280-e291. PubMed ID: 35427488
[TBL] [Abstract][Full Text] [Related]
8. New insights into Whipple's disease and Tropheryma whipplei infections.
Desnues B; Al Moussawi K; Fenollar F
Microbes Infect; 2010 Dec; 12(14-15):1102-10. PubMed ID: 20708091
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immune response to Tropheryma whipplei.
Ring S; Schneider T; Marth T
Int J Med Microbiol; 2003 Apr; 293(1):69-76. PubMed ID: 12755367
[TBL] [Abstract][Full Text] [Related]
10. Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease.
Dreier J; Szabados F; von Herbay A; Kröger T; Kleesiek K
J Clin Microbiol; 2004 Oct; 42(10):4487-93. PubMed ID: 15472298
[TBL] [Abstract][Full Text] [Related]
11. Tropheryma whipplei Increases Expression of Human Leukocyte Antigen-G on Monocytes to Reduce Tumor Necrosis Factor and Promote Bacterial Replication.
Ben Azzouz E; Boumaza A; Mezouar S; Bardou M; Carlini F; Picard C; Raoult D; Mège JL; Desnues B
Gastroenterology; 2018 Nov; 155(5):1553-1563. PubMed ID: 30076840
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of circulating IL-16 and apoptosis markers are related to the activity of Whipple's disease.
Benoit M; Fenollar F; Raoult D; Mege JL
PLoS One; 2007 Jun; 2(6):e494. PubMed ID: 17551575
[TBL] [Abstract][Full Text] [Related]
13. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei.
Al Moussawi K; Ghigo E; Kalinke U; Alexopoulou L; Mege JL; Desnues B
PLoS Pathog; 2010 Jan; 6(1):e1000722. PubMed ID: 20090833
[TBL] [Abstract][Full Text] [Related]
14. Tropheryma whipplei , Immunosuppression and Whipple's Disease: From a Low-Pathogenic, Environmental Infectious Organism to a Rare, Multifaceted Inflammatory Complex.
Marth T
Dig Dis; 2015; 33(2):190-199. PubMed ID: 25925922
[TBL] [Abstract][Full Text] [Related]
15. Tropheryma whipplei and Whipple's disease.
Fenollar F; Lagier JC; Raoult D
J Infect; 2014 Aug; 69(2):103-12. PubMed ID: 24877762
[TBL] [Abstract][Full Text] [Related]
16. Tropheryma whipplei infection and Whipple's disease.
Marth T; Moos V; Müller C; Biagi F; Schneider T
Lancet Infect Dis; 2016 Mar; 16(3):e13-22. PubMed ID: 26856775
[TBL] [Abstract][Full Text] [Related]
17. Human galectin-1 and galectin-3 promote
Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
[No Abstract] [Full Text] [Related]
18. Role of dendritic cells in the pathogenesis of Whipple's disease.
Schinnerling K; Geelhaar-Karsch A; Allers K; Friebel J; Conrad K; Loddenkemper C; Kühl AA; Erben U; Ignatius R; Moos V; Schneider T
Infect Immun; 2015 Feb; 83(2):482-91. PubMed ID: 25385798
[TBL] [Abstract][Full Text] [Related]
19. Global proteomic pattern of Tropheryma whipplei: a Whipple's disease bacterium.
Kowalczewska M; Villard C; Lafitte D; Fenollar F; Raoult D
Proteomics; 2009 Mar; 9(6):1593-616. PubMed ID: 19253299
[TBL] [Abstract][Full Text] [Related]
20. Tropheryma whipplei infective endocarditis as the only manifestation of Whipple's disease.
Marín M; Muñoz P; Sánchez M; del Rosal M; Rodríguez-Créixems M; Bouza E;
J Clin Microbiol; 2007 Jun; 45(6):2078-81. PubMed ID: 17446327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
